Presence of intestinal Mycobacterium avium subspecies paratuberculosis (MAP) DNA is not associated with altered MMP expression in ulcerative colitis

dc.contributor.authorRath, Timo
dc.contributor.authorRoderfeld, Martin
dc.contributor.authorBlöcher, Sonja
dc.contributor.authorRhode, Annika
dc.contributor.authorBasler, Tina
dc.contributor.authorAkineden, Ömer
dc.contributor.authorAbdulmawjood, Amir
dc.contributor.authorHalwe, Jörg M
dc.contributor.authorGoethe, Ralph
dc.contributor.authorBülte, Michael
dc.contributor.authorRoeb, Elke
dc.date.accessioned2022-11-18T09:55:57Z
dc.date.available2011-05-26T13:20:02Z
dc.date.available2022-11-18T09:55:57Z
dc.date.issued2011
dc.description.abstractBackground: Mycobacterium avium subspecies paratuberculosis (MAP) is suspected to be a causative agent in human Crohn´s disease (CD). Recent evidence suggests that pathogenic mycobacteria and MAP can induce the expression of Matrix Metalloproteinases (MMP), which are the main proteases in the pathogenesis of mucosal ulcerations in inflammatory bowel disease (IBD). Within this study we assessed the prevalence of intestinal MAP specific DNA in patients with Crohn´s disease, ulcerative colitis (UC), and healthy controls. We further analysed regulation patterns of MMPs in mucosal tissues of UC patients with and without intestinal MAP DNA detection.Methods: Colonic biopsy samples were obtained from 63 Norwegian and German IBD patients and 21 healthy controls. RNA was quantified by quantitative real-time polymerase chain reaction (PCR) to study MMP gene expression in both pathological and healthy mucosal specimens. The presence of MAP DNA in colonic mucosa was examined using MAP specific PCR.Results: MAP DNA was detected in 20% of UC patients and 33% of healthy controls but only in 7% of patients with CD. UC patients treated with corticosteroids exhibited a significantly increased frequency of intestinal MAP DNA compared to those not receiving corticosteroids. Expression of MMP-1, -2, -7, -9, -13, -19, -28 and TNF-alpha did not differ between UC patients with presence of intestinal MAP DNA compared to those without. MMP-2, MMP-9 and MMP-13 were significantly decreased in UC patients receiving corticosteroids.Conclusions: The presence of intestinal MAP specific DNA is not associated with altered MMP expression in UC in vivo. Corticosteroids are associated with increased detection of intestinal MAP DNA and decreased expression of certain MMPs. Frequent detection of MAP DNA in healthy controls might be attributable to the wide environmental distribution of MAP and its presence in the food-chain.en
dc.identifier.urihttp://nbn-resolving.de/urn:nbn:de:hebis:26-opus-81636
dc.identifier.urihttps://jlupub.ub.uni-giessen.de//handle/jlupub/9606
dc.identifier.urihttp://dx.doi.org/10.22029/jlupub-8994
dc.language.isoende_DE
dc.rightsNamensnennung 3.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by/3.0/*
dc.subjectMycobacterium avium paratubercolosis (MAP)en
dc.subjectCrohns disease (CD)en
dc.subjectMatrix Metalloproteinase (MMP)en
dc.subjectulcerative colitis (UC)en
dc.subject.ddcddc:610de_DE
dc.titlePresence of intestinal Mycobacterium avium subspecies paratuberculosis (MAP) DNA is not associated with altered MMP expression in ulcerative colitisen
dc.typearticlede_DE
local.affiliationFB 11 - Medizinde_DE
local.opus.fachgebietMedizinde_DE
local.opus.id8163
local.opus.instituteDepartment of Gastroenterology, Medical Clinic IIde_DE
local.source.freetextBMC Gastroenterology, 11:34de_DE
local.source.urihttps://doi.org/10.1186/1471-230X-11-34

Dateien

Originalbündel
Gerade angezeigt 1 - 1 von 1
Lade...
Vorschaubild
Name:
1471_230X_11_34.pdf
Größe:
1.14 MB
Format:
Adobe Portable Document Format